BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 965 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,649,183 | -27.2% | 138,989 | -6.9% | 0.01% | -30.8% |
Q1 2024 | $6,381,974 | +161.1% | 149,320 | +136.1% | 0.01% | +160.0% |
Q4 2023 | $2,444,666 | +38.0% | 63,237 | +34.7% | 0.01% | 0.0% |
Q3 2023 | $1,771,440 | -5.3% | 46,938 | +14.3% | 0.01% | 0.0% |
Q2 2023 | $1,870,739 | +32.7% | 41,061 | +18.1% | 0.01% | +25.0% |
Q1 2023 | $1,409,825 | -70.5% | 34,759 | -62.9% | 0.00% | -66.7% |
Q4 2022 | $4,771,811 | +59.0% | 93,620 | +68.0% | 0.01% | +20.0% |
Q3 2022 | $3,002,000 | -69.2% | 55,740 | -63.3% | 0.01% | -56.5% |
Q2 2022 | $9,754,000 | -60.7% | 151,846 | -52.6% | 0.02% | -45.2% |
Q1 2022 | $24,843,000 | -58.5% | 320,386 | -54.1% | 0.04% | -50.0% |
Q4 2021 | $59,861,000 | -31.0% | 697,339 | -35.3% | 0.08% | -45.1% |
Q3 2021 | $86,704,000 | +43.4% | 1,077,998 | +43.5% | 0.15% | +37.8% |
Q2 2021 | $60,479,000 | -6.3% | 751,282 | -1.8% | 0.11% | -11.9% |
Q1 2021 | $64,539,000 | +79.5% | 765,224 | +70.7% | 0.13% | +65.8% |
Q4 2020 | $35,961,000 | -9.0% | 448,169 | -8.8% | 0.08% | -29.0% |
Q3 2020 | $39,518,000 | -67.7% | 491,390 | -67.4% | 0.11% | -74.5% |
Q1 2020 | $122,325,000 | +1251.7% | 1,506,664 | +1292.1% | 0.42% | +1809.1% |
Q4 2019 | $9,050,000 | -36.7% | 108,231 | -33.7% | 0.02% | -47.6% |
Q3 2019 | $14,290,000 | +14.3% | 163,367 | +7.0% | 0.04% | -19.2% |
Q2 2019 | $12,507,000 | -1.0% | 152,705 | -1.7% | 0.05% | +4.0% |
Q1 2019 | $12,629,000 | +81.0% | 155,310 | +46.5% | 0.05% | +51.5% |
Q4 2018 | $6,978,000 | -53.6% | 106,018 | -45.7% | 0.03% | -50.7% |
Q3 2018 | $15,034,000 | +1.8% | 195,088 | -2.5% | 0.07% | -17.3% |
Q2 2018 | $14,770,000 | +6.1% | 200,028 | -6.6% | 0.08% | +12.5% |
Q1 2018 | $13,919,000 | -68.3% | 214,050 | -68.5% | 0.07% | -64.0% |
Q4 2017 | $43,911,000 | +154.6% | 679,324 | +147.1% | 0.20% | +98.0% |
Q3 2017 | $17,248,000 | -6.7% | 274,873 | -10.0% | 0.10% | +4.1% |
Q2 2017 | $18,494,000 | -46.6% | 305,502 | -54.3% | 0.10% | -34.5% |
Q1 2017 | $34,646,000 | +123.4% | 668,074 | +91.0% | 0.15% | +87.3% |
Q4 2016 | $15,507,000 | -61.3% | 349,731 | -58.4% | 0.08% | -65.2% |
Q3 2016 | $40,050,000 | -17.0% | 841,369 | -21.2% | 0.23% | -20.1% |
Q2 2016 | $48,271,000 | +11365.8% | 1,067,479 | +10327.7% | 0.28% | +9366.7% |
Q1 2016 | $421,000 | +9.4% | 10,237 | +1.4% | 0.00% | +50.0% |
Q4 2015 | $385,000 | +16.7% | 10,097 | +0.4% | 0.00% | 0.0% |
Q3 2015 | $330,000 | -98.6% | 10,057 | -97.1% | 0.00% | -98.3% |
Q2 2015 | $24,227,000 | +3.3% | 346,642 | +1.3% | 0.12% | +14.3% |
Q1 2015 | $23,451,000 | -6.5% | 342,337 | +0.1% | 0.10% | +9.4% |
Q4 2014 | $25,076,000 | +11.3% | 342,137 | +9.0% | 0.10% | +5.5% |
Q3 2014 | $22,524,000 | -0.6% | 313,837 | +0.1% | 0.09% | -2.2% |
Q2 2014 | $22,658,000 | -1.6% | 313,384 | +0.1% | 0.09% | -3.1% |
Q1 2014 | $23,037,000 | +21.5% | 313,087 | +14.8% | 0.10% | +20.0% |
Q4 2013 | $18,962,000 | +3917.4% | 272,638 | +3690.9% | 0.08% | +3900.0% |
Q3 2013 | $472,000 | -11.3% | 7,192 | -6.5% | 0.00% | -33.3% |
Q2 2013 | $532,000 | -2.9% | 7,690 | +1.9% | 0.00% | 0.0% |
Q1 2013 | $548,000 | – | 7,547 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |